|
Richard HensonMedical Technology
|
Richard Henson is a medical device executive with over 35 years of experience in senior management, business development, product development, design, and manufacturing. He is the CEO of DeviceWorks, Inc., an Orange County based medical device design and development firm.
His career includes working with multiple Fortune 500 companies in the US and Europe including Switzerland. He has co-founded multiple medical device companies including Helix Cardia, Inc. and ValVention, Inc. - both pre-clinical cardiovascular technology firms. He also co-founded PhageTech, Inc, a development stage company that is developing novel technology for immunodiagnostics.
Previously, he was co-founder and CEO of Source Scientific LLC, a medical device development firm that was ranked in 2012 as one of the Inc. 5000 fastest growing companies in the US. Here, he and his partners developed original technology for in-vitro diagnostics. Source Scientific developed and manufactured products for many well-known diagnostic, ophthalmic, surgical and medical device companies.
His career includes working with multiple Fortune 500 companies in the US and Europe including Switzerland. He has co-founded multiple medical device companies including Helix Cardia, Inc. and ValVention, Inc. - both pre-clinical cardiovascular technology firms. He also co-founded PhageTech, Inc, a development stage company that is developing novel technology for immunodiagnostics.
Previously, he was co-founder and CEO of Source Scientific LLC, a medical device development firm that was ranked in 2012 as one of the Inc. 5000 fastest growing companies in the US. Here, he and his partners developed original technology for in-vitro diagnostics. Source Scientific developed and manufactured products for many well-known diagnostic, ophthalmic, surgical and medical device companies.
